PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
1998 | 03 | 4 |

Tytuł artykułu

Polymorphisms of human IL-1b and IL-1 antagonist genes and their informativity for the association studies

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Several genetic and immunological studies showed that interleukin-1 (IL-1) is involved in pathogenesis of immune-related disorders e.g. type 1 diabetes, autoimmune thyroiditis or inflammatory bowel disease. Association studies performed till now are rather inconclusive, possibly because investigated markers chosen were not enough informative. The aim of the present study is to elucidate how informative for association screening is the occurrence of known polymorphisms located within genes encoding IL-1β (IL-1B) and IL-1 antagonist (IL-1RN) in Polish population. The following substitutions were analyzed by PCR based techniques: T→C within the promotor region, G→A in intron 4 and C→T in exon 5 of IL-1B gene as well as T→C in exon 2, T→C in exon 4 and the polymorphism of variable number of tandem repeats (VNTR) of 86 base pairs within intron 2 of IL-1RN gene. Obtained results proved the occurrence of all studied polymorphisms in Polish population. Combination of haplotypes related to three novel IL-1B gene dimorphisms reveals that PIC value 0.77 (polymorphic information contents) is similar to that of microsatellite markers. Thus, it is possible that the combination of revealed polymorphisms makes together new marker applicable for the genetic association studies more sensitive then markers previously used.

Wydawca

-

Rocznik

Tom

03

Numer

4

Opis fizyczny

p.379-388

Twórcy

autor
  • Medical University of Lodz, Sporna 36-50, 91-738 Lodz, Poland
autor
autor

Bibliografia

  • 1. Mandrup-Poulsen, T. Diabetologia 39 (1996) 1005-1029.
  • 2. Eizirik, D. L., Welsh N., and Hellerstrom. J. Clin. Endocrinol. Methabol. 76 (1993) 399-403.
  • 3. Eizirik, D. L., Bjorklund, A. and Welsh, N. FEBS 317 (1993) 62-66.
  • 4. Lennard, A. C. Crit. Rev. Immunol. 15 (1995) 77-105.
  • 5. Lennard, A., Gorman, P., Carrier, M., Griffiths, S., Scotney, H., Sheer, D. and Solari, R. Cytokine 4 (1992) 83-89.
  • 6. Tarlow, J. K., Blakemore, A. L., Lennard, A., Solari, R., Hughes, H. N. and Steinkasserer, A. Hum. Genet. 91 (1993) 403-404.
  • 7. Daser, A., Mitchison, H., Mitchison, A. and Muller, B. Cytokine 8 (1996) 593-597.
  • 8. Mansfield, J. C., Holden, H., Tarlow, J. K., di Giovine, F. S. McDowell, T. L., Wilson, A. G., Holdsworth, C. D. and Duff, G. W. Gastroenterology 106 (1994) 637-642.
  • 9. Blakemore, A.I., Watson, P. E., Weetman, A. P. and Duff, G. W. J. Clin. Endocrinol. Methabol. 80 (1994) 111-115.
  • 10. Cork, M. J., Tarlow, J. K., Blakemore, A. I. F., McDonagh, J. G., Messenger, A. G., Blechen, S. S. and Duff, G. W. J. Invest. Dermatol. 100 (1993) 552-558.
  • 11. Steinkasserer, A., Spurr, N. K., Cox, S., Jeggo, P. and Sim, R. B. Genomics 13 (1992) 654-657.
  • 12. Pociot, F., Ronningen, K. S., Bergholdt, R., Lorenzen, T., Johannesen, J., Ye, K., Dinarello, C. A. and Nerup, J. Autoimmunity 19 (1994) 169-178.
  • 13. Todd, S. and Naylor, S. L. Nucleic Acids Res. 19 (1991) 3756.
  • 14. Guasch, J. F., Bertina, R. M. and Reitsma, P. H. Cytokine 8 (1996) 598-602.
  • 15. Pociot, F., Molvig, J., Wogensen, L. D. Worsaae, H., and Nerup, J. Eur. J. Clin. Invest. 22 (1992) 386-402.
  • 16. Hacker, U. T., Gomolka, M., Keller, E., Eigler, A., Folwaczny, C., Fricke, H., Albert, E., Loeschke, K. and Endres, S. Gut 40 (1997) 623-627.
  • 17. Cuddihy, R. M. and Bahn, R. S. J. Clin. Endocrinol. Methabol. 81 (1996) 4476-4478.
  • 18. Clark, B. D., Collins, K. L. Gandy, M. S., Webb, A. C. and Auron, P. E. Nucleic Acids Res. 14 (1986) 7879-7914.
  • 19. Terwilliger, J. and Ott, J. Handbook for Human Genetic Linkage. Baltimore. Maryland: John Hopkins University Press, 1994, 1st edition.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-3aed6f51-29e7-4cc5-8e6e-e05956654384
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.